Medical terminology

G-W Publisher and SkillsUSA partner for 2022 Championship competitions

Retrieved on: 
Thursday, June 16, 2022

TINLEY PARK, Ill., June 16, 2022 /PRNewswire-PRWeb/ -- Goodheart-Willcox (G-W), a leading publisher of learning materials and digital solutions, and SkillsUSA, a national association that prepares students for careers in trade, technical, and skilled service occupations, have established a new partnership surrounding the SkillsUSA Championships.

Key Points: 
  • "These assessments are an accurate measure of knowledge that helps keep SkillsUSA students up to date with current industry technology.
  • The SkillsUSA Championships take place as part of the National Leadership & Skills Conference in Atlanta June 2024, 2022.
  • G-W will have a sample of each title featured in the 2022 SkillsUSA Championship competitions in Booth #361 at the SkillsUSA TECHSPO trade show.
  • Driven by employer demand, SkillsUSA helps students develop necessary personal and workplace skills along with technical skills grounded in academics.

The Village School Announces Pre-Medical Science Diploma Program for High School Students

Retrieved on: 
Tuesday, March 8, 2022

HOUSTON, March 8, 2022 /PRNewswire/ -- The Village School, a premier PreK-12 private day and boarding school in Houston, recently announced it will offer a Pre-Medical Science diploma for its high school students interested in pursuing a career in medicine beginning in the Fall of 2022.The Village School is one of the only private schools in Houston to offer a Pre-Medical Science diploma program.

Key Points: 
  • HOUSTON, March 8, 2022 /PRNewswire/ -- The Village School, a premier PreK-12 private day and boarding school in Houston, recently announced it will offer a Pre-Medical Science diploma for its high school students interested in pursuing a career in medicine beginning in the Fall of 2022.The Village School is one of the only private schools in Houston to offer a Pre-Medical Science diploma program.
  • Village's Pre-Medical Science diploma is a career-specific program which prepares students for the next step in their pre-medical education.
  • Through this collaboration, The Village School will become the first high school program in the world to utilize the complete Blausen Anatomy & Physiology experience.
  • Students participating in the program will be introduced to:
    For more information about The Village School and the new diploma program, visit thevillageschool.com .

New Relias Platform Helps Acute Care Providers Maximize Revenue

Retrieved on: 
Tuesday, November 16, 2021

The Relias Revenue Cycle and Coding curriculum is among the most comprehensive in the market, with more than 700 lessons covering the complete revenue cycle --  from the first interaction with a patient all the way through to when there is a $0 balance on a claim.

Key Points: 
  • "With this portfolio, Relias offers the education acute care providers need to ensure complete and accurate reimbursement and avoid the all-too-common and often prolonged billing disputes, denied claims, and incorrect payments that can result from coding errors," said Ross Golden, chief financial officer at Relias.
  • Relias Revenue Cycle and Coding curriculum covers all of these areas, including courses on denial management," said Barbara Nelson Cullen, senior product manager at Relias.
  • Course offerings include Finance and Revenue Cycle, Coding, Risk Adjustment, Clinical Documentation Improvement, HIPAA and Corporate Compliance, Human Body Essentials and Medical Terminology.
  • For more than 11,000 healthcare organizations and 4.5 million caregivers, Relias continues to help clients deliver better clinical and financial outcomes by reducing variation in care.

Ocular Therapeutix™ Reports Third Quarter 2021 Financial Results and Business Update

Retrieved on: 
Monday, November 8, 2021

Net product revenue of DEXTENZA for the quarter was $11.9 million, a 120% increase over the third quarter of 2020 and a 7% sequential improvement over the second quarter of 2021.

Key Points: 
  • Net product revenue of DEXTENZA for the quarter was $11.9 million, a 120% increase over the third quarter of 2020 and a 7% sequential improvement over the second quarter of 2021.
  • Four Company-sponsored and investigator-initiated presentations were made at the American Academy of Optometry (AAOPT) Annual Meeting 2021 November 3 - 6, 2021.
  • General and administrative expenses were $8.1 million for the third quarter versus $6.0 million in the comparable quarter of 2020.
  • Members of the Ocular Therapeutix management team will host a live conference call and webcast today at 4:30 pm Eastern Time to review the Company's financial results and provide a general business update.

Ocular Therapeutix™ Announces Update from the Centers for Medicare and Medicaid Services (CMS) for the Reimbursement of DEXTENZA®

Retrieved on: 
Friday, November 5, 2021

The OPPS final rule confirms that DEXTENZA will continue to be separately paid by Medicare in the hospital outpatient department (HOPD) and ambulatory surgical center (ASC) settings for 2022.

Key Points: 
  • The OPPS final rule confirms that DEXTENZA will continue to be separately paid by Medicare in the hospital outpatient department (HOPD) and ambulatory surgical center (ASC) settings for 2022.
  • The physician payment for the insertion of DEXTENZA in the physician office is $37.29 and in the ASC or the HOPD is $31.58.
  • Ocular Therapeutixs first commercial drug product, DEXTENZA, is an FDA-approved corticosteroid for the treatment of ocular inflammation and pain following ophthalmic surgery and ocular itching associated with allergic conjunctivitis.
  • Ocular Therapeutix's first product, ReSure Sealant, is an FDA-approved device to prevent wound leaks in corneal incisions following cataract surgery.

The Worldwide Neurovascular Devices Industry is Expected to Reach $3.4+ Billion by 2026 - ResearchAndMarkets.com

Retrieved on: 
Monday, September 6, 2021

The demand for neurovascular devices is expected to surge due to the rise in the geriatric population, globally.

Key Points: 
  • The demand for neurovascular devices is expected to surge due to the rise in the geriatric population, globally.
  • The report also stated that the number of older people, worldwide, is expected to double to 1.5 million in the year 2050.
  • With the rise in neurological and neurovascular problems, the demand for neurovascular devices is expected to surge in the coming years.
  • These developments are expected to accelerate the demand for neurovascular devices in the region, in the coming years.

G1 Therapeutics Granted New Technology Add-On Payment (NTAP) for COSELA™ (Trilaciclib) by Centers for Medicare & Medicaid Services (CMS)

Retrieved on: 
Wednesday, August 4, 2021

An NTAP provides additional payment to hospitals above the standard Medicare Severity Diagnosis-Related Group (MS-DRG) payment amount.

Key Points: 
  • An NTAP provides additional payment to hospitals above the standard Medicare Severity Diagnosis-Related Group (MS-DRG) payment amount.
  • As such, beginning on October 1, 2021, CMS will provide an additional maximum payment of$5,526.30for COSELA when used in the inpatient hospital setting for fiscal year 2022.
  • G1 Therapeutics is based in Research Triangle Park, N.C. For additional information, please visit www.g1therapeutics.com and follow us on Twitter @G1Therapeutics .
  • G1 Therapeutics and the G1 Therapeutics logo and COSELA and the COSELA logo are trademarks of G1 Therapeutics, Inc.

UnitedHealthcare and Tennessee Initiative for Perinatal Quality Care Focus on Health Equity in Maternal Health Outcomes

Retrieved on: 
Wednesday, August 4, 2021

UnitedHealthcare and Nashville-based Tennessee Initiative for Perinatal Quality Care (TIPQC) today announced a maternal health initiative aimed at improving maternal and infant health outcomes and equity throughout the state.

Key Points: 
  • UnitedHealthcare and Nashville-based Tennessee Initiative for Perinatal Quality Care (TIPQC) today announced a maternal health initiative aimed at improving maternal and infant health outcomes and equity throughout the state.
  • With $280,000 in funding from UnitedHealthcare, the initiative will focus on maternal hypertension and hemorrhage simulation training for hospitals in Tennessee and support remote monitoring capabilities for perinatal patients.
  • We hope this new partnership is an important step toward addressing a leading cause of severe maternal morbidity and helps improve health outcomes in Tennessee.
  • The Tennessee Initiative for Perinatal Quality Care (TIPQC) is the states perinatal quality collaborative.

Generations Homecare System Introduces Electronic Visit Verification Solution for Idaho

Retrieved on: 
Wednesday, August 4, 2021

This exciting news means Idaho homecare providers can seamlessly bill Medicaid in addition to meeting state Electronic Visit Verification (EVV) requirements under the 21st Century Cures Act.

Key Points: 
  • This exciting news means Idaho homecare providers can seamlessly bill Medicaid in addition to meeting state Electronic Visit Verification (EVV) requirements under the 21st Century Cures Act.
  • Homecare teams in Idaho that use Generations benefit from:
    "The Sandata interface for agencies in Idaho is the latest Sandata interface from our team.
  • We are pleased to help agencies in Idaho maintain compliance using the new interface," Lance Ferden, Generations Homecare System Co-Founder and Chief Technical Officer.
  • Generations Homecare System is an application that gives homecare providers the power to improve care outcomes, boost referrals, and streamline day-to-day tasks.

RXNT Named "Best E-Prescribing Software" of 2021

Retrieved on: 
Wednesday, August 4, 2021

ANNAPOLIS, Md., Aug. 4, 2021 /PRNewswire-PRWeb/ -- RXNT , an industry-leading provider of cloud-based ambulatory healthcare software, today announced that it has been selected as one of the Best E-Prescribing Software companies of 2021 by Digital.com, an independent review website for small businesses and startups.

Key Points: 
  • ANNAPOLIS, Md., Aug. 4, 2021 /PRNewswire-PRWeb/ -- RXNT , an industry-leading provider of cloud-based ambulatory healthcare software, today announced that it has been selected as one of the Best E-Prescribing Software companies of 2021 by Digital.com, an independent review website for small businesses and startups.
  • The research team conducted over 40 hours of assessment on more than 75 e-prescribing software companies from across the web to create the report.
  • "We are excited to once again stand out as a leader in the growing and evolving HealthIT market," said Randy Boldyga, CEO and President of RXNT.
  • RXNT was recognized based on its core features like medication history, clinical alerts, prescription cancellation and renewals, and refill management.